Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

Survey of Early Adopters of Peptide Receptor Radionuclide Therapy with Lu-177-dotatate in the USA

Einat Slonimsky and Mark Tulchinsky
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1441;
Einat Slonimsky
1Radiology Penn State Health, Milton S. Hershey Med. Center Hershey PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark Tulchinsky
2Penn State Health, Milton S. Hershey Med. Center Hershey PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 61 no. supplement 1 1441

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2020.

Copyright & Usage 
© 2020

Author Information

  1. Einat Slonimsky1 and
  2. Mark Tulchinsky2
  1. 1Radiology Penn State Health, Milton S. Hershey Med. Center Hershey PA United States
  2. 2Penn State Health, Milton S. Hershey Med. Center Hershey PA

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2020 to April 2025

AbstractFullPdf
May 2020600
Jun 20203300
Jul 20201800
Aug 20203700
Sep 2020800
Oct 20202700
Nov 20201000
Dec 20201200
Jan 2021700
Feb 20211600
Mar 20211900
Apr 20217400
May 20213900
Jun 20213100
Jul 20219000
Aug 202114300
Sep 20211100
Oct 2021300
Nov 20211200
Dec 2021200
Jan 2022300
Feb 2022300
Mar 2022800
Apr 2022900
May 2022300
Jun 2022600
Jul 2022600
Aug 2022600
Sep 2022400
Oct 2022300
Nov 2022100
Dec 2022500
Jan 2023600
Feb 2023700
Mar 2023400
Apr 2023500
May 2023100
Jun 2023200
Jul 2023400
Aug 2023100
Sep 2023200
Oct 2023100
Nov 2023500
Dec 2023500
Jan 2024200
Feb 2024600
Mar 2024300
Apr 2024300
May 2024700
Jun 2024200
Jul 2024100
Aug 2024300
Sep 2024300
Oct 2024600
Nov 2024600
Dec 2024500
Feb 2025600
Mar 2025600
Apr 2025800
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Survey of Early Adopters of Peptide Receptor Radionuclide Therapy with Lu-177-dotatate in the USA
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Survey of Early Adopters of Peptide Receptor Radionuclide Therapy with Lu-177-dotatate in the USA
Einat Slonimsky, Mark Tulchinsky
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1441;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Survey of Early Adopters of Peptide Receptor Radionuclide Therapy with Lu-177-dotatate in the USA
Einat Slonimsky, Mark Tulchinsky
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 1441;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Comparison of Manual and Computer-Generated Methods for Segmentation of the Aorta in Lymphoma Patients from PET/CT Imaging
  • Radiolabeled hyaluronic acid (HA) fragments for lymphatic imaging
  • Rest Dose Spillover Correction of Stress Blood Flow Measurements in Digital Rb-82 Myocardial Perfusion PET/CT Imaging
Show more

Endocrine/Neuroendocrine (Therapy/Non-Therapy) Poster Session

  • I-131 MIBG therapy has been used as the first line therapy in pheochromocytoma
  • 131I effective half-life in children and adolescents with thyroid cancer patients
  • Applicationof compound iodine oral solution in 131I treatment of severe hyperthyroidism.
Show more Endocrine/Neuroendocrine (Therapy/Non-Therapy) Poster Session

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire